EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Presentation and management of patients with adrenal masses: a large tertiary centre experience

Onnicha Suntornlohanakul iD, Sumedha Mandal, Pratyusha Saha, Emre S Saygili, Miriam Asia, Wiebke Arlt iD, Yasir S Elhassan iD, Alessandro Prete iD, Cristina L Ronchi iD

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Onnicha Suntornlohanakul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham B152TT, United Kingdom. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Tertiary Care Centers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Reference Network on Rare Endocrine Conditions, European Commission Horizon 2022 Program, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adrenal masses are found in up to 5%-7% of adults. The 2016 European guidelines on the management of adrenal incidentalomas have standardised the workup of these patients, but evidence of their impact on clinical practice is lacking.

Methods

Retrospective review of clinical presentation, radiological characteristics, and final diagnosis of a large cohort of patients with adrenal masses referred to a tertiary care centre 1998-2022. Sub-analysis compares outcomes before and after implementing the 2016 guidelines.

Results

A total of 1397 patients (55.7% women; median age 60 years [interquartile range {IQR}, 49-70]) were included. Incidental discovery was the most frequent mode of presentation (63.7%) and 30.6% of patients had masses ≥ 4 cm (median 2.9 cm [IQR, 1.9-4.7]). Unenhanced computed tomography Hounsfield units (HU) were available for 763 patients; of these, 32.9% had heterogeneous masses or >20 HU. The most common diagnoses were adrenocortical adenoma (56.0%), phaeochromocytoma (12.7%), adrenocortical carcinoma (10.6%), and metastases (5.7%). At multivariable analysis, significant predictors of malignancy included >20 HU or heterogeneous density (odds ratio [OR] 28.40), androgen excess (OR 27.67), detection during cancer surveillance (OR 11.34), size ≥ 4 cm (OR 6.11), and male sex (OR 3.06). After implementing the 2016 guidelines, the number of adrenalectomies decreased (6.1% pre-2016 vs 4.5% post-2016) and the number of patients discharged increased (4.4% pre-2016 vs 25.3% post-2016) for benign non-functioning adrenal masses.

Conclusion

Implementing the 2016 guidelines positively impacted clinical practice, reducing unnecessary surgeries and increasing the discharge rate for benign adrenal masses, thereby preserving healthcare resources and patient burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Gland NeoplasmsTertiary Care CentersHumansFemaleMaleMiddle AgedRetrospective StudiesAgedPheochromocytomaTomography, X-Ray ComputedAdultAdrenalectomyPractice Guidelines as TopicIncidental FindingsAdrenocortical Adenoma

Stichwörter der Autor:innen

adrenal incidentaloma guidelinesadrenal tumouradrenocortical adenomaadrenocortical carcinoma

Autor:innen und Institutionen

  • Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham B152TT, United Kingdom.
  • Endocrinology and Metabolism Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham B152TT, United Kingdom.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey.
  • Department of Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham B152GW, United Kingdom.
  • Medical Research Council Laboratory of Medical Sciences, London W120NN, United Kingdom.

ORCID-Profile: Onnicha Suntornlohanakul, Wiebke Arlt, Yasir S Elhassan, Alessandro Prete, Cristina L Ronchi

Förderung

  • European Reference Network on Rare Endocrine Conditions
  • European Commission Horizon 2022 Program
  • National Institute for Health and Care Research
  • Birmingham Biomedical Research Centre
  • HRA Pharma Rare Disease

Zitieren

APA

Suntornlohanakul, O., Mandal, S., Saha, P., Saygili, E. S., Asia, M., Arlt, W., Elhassan, Y. S., Prete, A., & Ronchi, C. L. (2024). Presentation and management of patients with adrenal masses: a large tertiary centre experience. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae131

Vancouver

Suntornlohanakul O, Mandal S, Saha P, Saygili ES, Asia M, Arlt W, et al. Presentation and management of patients with adrenal masses: a large tertiary centre experience. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae131

BibTeX
@article{Suntornlohanakul2024,
  author = {Suntornlohanakul, Onnicha and Mandal, Sumedha and Saha, Pratyusha and Saygili, Emre S and Asia, Miriam and Arlt, Wiebke and Elhassan, Yasir S and Prete, Alessandro and Ronchi, Cristina L},
  title = {Presentation and management of patients with adrenal masses: a large tertiary centre experience},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae131}
}
Kostenlos starten →